CN103638242A - Traditional Chinese medicine composition for treating prostatic hyperplasia - Google Patents

Traditional Chinese medicine composition for treating prostatic hyperplasia Download PDF

Info

Publication number
CN103638242A
CN103638242A CN201310532799.4A CN201310532799A CN103638242A CN 103638242 A CN103638242 A CN 103638242A CN 201310532799 A CN201310532799 A CN 201310532799A CN 103638242 A CN103638242 A CN 103638242A
Authority
CN
China
Prior art keywords
parts
radix
herba
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310532799.4A
Other languages
Chinese (zh)
Inventor
陈飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310532799.4A priority Critical patent/CN103638242A/en
Publication of CN103638242A publication Critical patent/CN103638242A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a traditional Chinese medicine composition for treating prostatic hyperplasia, which is composed of raw materials by weight: 8-10 parts of pseudo-ginseng, 2-4 parts of oyster, 3-5 parts of cyathula roots, 1-3 parts of oriental waterplantain rhizomes, 3-5 parts of morinda roots, 2-3 parts of cuscuta seeds, 5-6 parts of astragalus roots, 9-11 parts of myrrh, 4-6 parts of fried large-headed atractylodes, 2-4 parts of areca peels, 1-2 parts of rhaponticum, 6-8 parts of licorice, 3-5 parts of vaccaria seeds, 5-7 parts of dandelion, 2-4 parts of human placenta, 1-3 parts of oldenlandia, 2-4 parts of kalimeris, 2-4 parts of common sage herbs, 1-2 parts of arrowhead leaves and 1-2 parts of agrimony. The invention provides a compatibility of traditional Chinese medicines, which has efficacies for nourishing yin and blood, adjusting and nourishing liver and kidney, relaxing vein and activating blood, reducing heat and treating stranguria; The present invention can treat prostatic hyperplasia with good curative effect and fast effectiveness without any toxic and side effects.

Description

A kind of Chinese medicine composition for the treatment of prostate hyperplasia
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of prostate hyperplasia, belong to the field of Chinese medicines.
Background technology
Prostate hyperplasia is that kind of prostate obviously increases and unhealthful commonly encountered diseases, symptom mainly contains frequent micturition, dysuria and urinary retention, if do not treated, will be developed to uremia, the Chinese medicine of specially controlling at present prostate hyperplasia is not a lot, as Qianliekangshu Capsule, blue classical pollen capsule etc., these medicines can alleviate the symptom of prostatic hyperplasia, but can not eradicate focus completely, curative effect is not ten obvious.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of prostate hyperplasia.
The present invention adopts following technical scheme:
The Chinese medicine composition for the treatment of prostate hyperplasia, the weight portion of its constitutive material is: Radix Notoginseng 8-10, Concha Ostreae 2-4, Radix Cyathulae 3-5, Rhizoma Alismatis 1-3, Radix Morindae Officinalis 3-5, Semen Cuscutae 2-3, Radix Astragali 5-6, Myrrha 9-11, Rhizoma Atractylodis Macrocephalae (parched) 4-6, Pericarpium Arecae 2-4, Radix Rhapontici 1-2, Radix Glycyrrhizae 6-8, Semen Vaccariae 3-5, Herba Taraxaci 5-7, Placenta Hominis 2-4, Herba Hedyotidis Diffusae 1-3, Herba Kalimeridis 2-4, favus grass 2-4, Folium sagittariae sagittifoliae 1-2 and Herba Lespedezae Cuneatae 1-2.
The Chinese medicine composition for the treatment of prostate hyperplasia, the weight portion of its constitutive material is: Radix Notoginseng 9, Concha Ostreae 3, Radix Cyathulae 4, Rhizoma Alismatis 2, Radix Morindae Officinalis 4, Semen Cuscutae 2.5, the Radix Astragali 5.5, Myrrha 10, Rhizoma Atractylodis Macrocephalae (parched) 5, Pericarpium Arecae 3, Radix Rhapontici 1.5, Radix Glycyrrhizae 7, Semen Vaccariae 4, Herba Taraxaci 6, Placenta Hominis 3, Herba Hedyotidis Diffusae 2, Herba Kalimeridis 3, favus's grass 3, Folium sagittariae sagittifoliae 1.5 and Herba Lespedezae Cuneatae 1.5.
By the weight portion of constitutive material, take each raw material, decoct 20-30 minute, then boil with high heat and use again slow fire instead and decoct 10-15 minute, remove medicinal residues, get decoction, potion on the one, potion is taken at twice, a month course for the treatment of.
Beneficial effect of the present invention:
The all medicine compatibilities of Chinese medicine of the present invention, have nourishing YIN and benefiting blood, adjusting and reinforcing liver and kidney, and dredging collateral is invigorated blood circulation, and treating stranguria effect expels the heat-evil; Treatment prostate hyperplasia good effect, instant effect, without any side effects.
The specific embodiment
Embodiment 1: the Chinese medicine composition for the treatment of prostate hyperplasia, the weight portion of its constitutive material (g) is: Radix Notoginseng 9, Concha Ostreae 3, Radix Cyathulae 4, Rhizoma Alismatis 2, Radix Morindae Officinalis 4, Semen Cuscutae 2.5, the Radix Astragali 5.5, Myrrha 10, Rhizoma Atractylodis Macrocephalae (parched) 5, Pericarpium Arecae 3, Radix Rhapontici 1.5, Radix Glycyrrhizae 7, Semen Vaccariae 4, Herba Taraxaci 6, Placenta Hominis 3, Herba Hedyotidis Diffusae 2, Herba Kalimeridis 3, favus's grass 3, Folium sagittariae sagittifoliae 1.5 and Herba Lespedezae Cuneatae 1.5.
By the weight portion of constitutive material, take each raw material, decoct 20-30 minute, then boil with high heat and use again slow fire instead and decoct 10-15 minute, remove medicinal residues, get decoction, potion on the one, potion is taken at twice, a month course for the treatment of.
Model case:
Case 1: week certain, man, 65 years old, suffers from prostate hyperplasia, dysuria, urine is waited for, urinates line thin, dribbling, intravenous pharmacy and topical therapeutic, effect inequality, take Chinese medicine composition of the present invention, every day potion, potion is taken at twice, take after the course for the treatment of, urine is waited for, the thin symptom of urine line is clearly better, and continues to take after the course for the treatment of, without any ill symptoms, recovery from illness, so far not recurrence.
Case 2: Zhu, man, 62 years old, suffer from prostate hyperplasia, with symptoms such as frequent micturition, urgent micturition, urine waits, get up night often, hospitalization, the state of an illness has no improvement, takes Chinese medicine composition of the present invention, every day potion, potion is taken at twice, takes after 20 doses, frequent micturition, urgent micturition, urine wait for that symptom is clearly better, continue to take after two courses for the treatment of recovery from illness, so far not recurrence.
Case 3: relax certain, man, 57 years old, long-term frequent micturition, urgent micturition, urine were waited for, the prostate B of hospital is super to be shown: prostate 5.2cm * 4.6cm * 4.2cm, take Chinese medicine composition of the present invention, every day potion, potion is taken at twice, takes after two courses for the treatment of, without any ill symptoms.

Claims (2)

1. treat a Chinese medicine composition for prostate hyperplasia, it is characterized in that the weight portion of its constitutive material is: Radix Notoginseng 8-10, Concha Ostreae 2-4, Radix Cyathulae 3-5, Rhizoma Alismatis 1-3, Radix Morindae Officinalis 3-5, Semen Cuscutae 2-3, Radix Astragali 5-6, Myrrha 9-11, Rhizoma Atractylodis Macrocephalae (parched) 4-6, Pericarpium Arecae 2-4, Radix Rhapontici 1-2, Radix Glycyrrhizae 6-8, Semen Vaccariae 3-5, Herba Taraxaci 5-7, Placenta Hominis 2-4, Herba Hedyotidis Diffusae 1-3, Herba Kalimeridis 2-4, favus grass 2-4, Folium sagittariae sagittifoliae 1-2 and Herba Lespedezae Cuneatae 1-2.
2. the Chinese medicine composition for the treatment of prostate hyperplasia according to claim 1, is characterized in that the weight portion of its constitutive material is: Radix Notoginseng 9, Concha Ostreae 3, Radix Cyathulae 4, Rhizoma Alismatis 2, Radix Morindae Officinalis 4, Semen Cuscutae 2.5, the Radix Astragali 5.5, Myrrha 10, Rhizoma Atractylodis Macrocephalae (parched) 5, Pericarpium Arecae 3, Radix Rhapontici 1.5, Radix Glycyrrhizae 7, Semen Vaccariae 4, Herba Taraxaci 6, Placenta Hominis 3, Herba Hedyotidis Diffusae 2, Herba Kalimeridis 3, favus's grass 3, Folium sagittariae sagittifoliae 1.5 and Herba Lespedezae Cuneatae 1.5.
CN201310532799.4A 2013-11-04 2013-11-04 Traditional Chinese medicine composition for treating prostatic hyperplasia Pending CN103638242A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310532799.4A CN103638242A (en) 2013-11-04 2013-11-04 Traditional Chinese medicine composition for treating prostatic hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310532799.4A CN103638242A (en) 2013-11-04 2013-11-04 Traditional Chinese medicine composition for treating prostatic hyperplasia

Publications (1)

Publication Number Publication Date
CN103638242A true CN103638242A (en) 2014-03-19

Family

ID=50243614

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310532799.4A Pending CN103638242A (en) 2013-11-04 2013-11-04 Traditional Chinese medicine composition for treating prostatic hyperplasia

Country Status (1)

Country Link
CN (1) CN103638242A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111465403A (en) * 2017-12-06 2020-07-28 赫利世弥斯株式会社 Herbal composition for preventing or treating prostatic hypertrophy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111465403A (en) * 2017-12-06 2020-07-28 赫利世弥斯株式会社 Herbal composition for preventing or treating prostatic hypertrophy
EP3721891A4 (en) * 2017-12-06 2021-06-09 Helixmith Co., Ltd Herbal composition for preventing or treating benign prostatic hyperplasia disease

Similar Documents

Publication Publication Date Title
CN101129620A (en) Traditional Chinese medicine for treating nasosinusitis headache
CN103316295B (en) Traditional Chinese composition for treating rheumatic arthritis
CN103316298B (en) Traditional Chinese composition for treating arthralgia
CN103212021A (en) Traditional Chinese medicine composition used for treating chloasma
CN101152494A (en) Traditional Chinese medicine for treating acute appendicitis
CN104998202A (en) Traditional Chinese medicine for treating cervical spondylosis
CN102552729B (en) Medicament for treating mesangial proliferative glomerulonephritis
CN101623413A (en) Chinese medicinal composition for treating women mastitis
CN101085088A (en) Traditional Chinese medicine formula for treating prostatic hyperplasia
CN103550679A (en) Traditional Chinese medicine formula for treatment of lithangiuria
CN103638242A (en) Traditional Chinese medicine composition for treating prostatic hyperplasia
CN104644857A (en) Traditional Chinese medicine formula for treating acnes
CN102579678B (en) Medicinal composition for treating vitligo
CN104324280A (en) Traditional Chinese medicine composition for treating nasopharynx cancer and preparation method of traditional Chinese medicine composition
CN101152293A (en) Traditional Chinese medicine for treating dacryocystitis of liver rheumatic fever rise
CN104587385A (en) Traditional Chinese medicine composition for treating blood stasis condensation type rosacea
CN102784212A (en) Chinese medicine composition for treating arthralgia-synadrome
CN104027430A (en) Traditional Chinese medicine composition for treating blood stasis type uterine myoma
CN103446535A (en) Miao ethnomedicine for treating coronary heart disease
CN101152300A (en) Traditional Chinese medicine for treating stasis accumulation intestinal obstruction
CN1175874C (en) Medicine made of chuan-xing rhizome for treating thromboangitis obliterans and its presciption
CN101152410A (en) Traditional Chinese medicine for treating alopecia
CN101002853A (en) Oral medicine for treating cephalagra type hemidrosis
CN105233103A (en) Traditional Chinese medicine decoction for treating urinary tract infection
CN105749243A (en) Traditional Chinese medicine for treating coolness diseases

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140319